Cargando…
Optimal designs for group randomized trials and group administered treatments with outcomes at the subject and group level
With group randomized trials complete groups of subject are randomized to treatment conditions. Such grouping also occurs in individually randomized trials where treatment is administered in groups. Outcomes may be measured at the level of the subject, but also at the level of the group. The optimal...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7082894/ https://www.ncbi.nlm.nih.gov/pubmed/31041883 http://dx.doi.org/10.1177/0962280219846149 |
_version_ | 1783508431022325760 |
---|---|
author | Moerbeek, Mirjam |
author_facet | Moerbeek, Mirjam |
author_sort | Moerbeek, Mirjam |
collection | PubMed |
description | With group randomized trials complete groups of subject are randomized to treatment conditions. Such grouping also occurs in individually randomized trials where treatment is administered in groups. Outcomes may be measured at the level of the subject, but also at the level of the group. The optimal design determines the number of groups and the number of subjects per group in the intervention and control conditions. It is found by taking a budgetary constraint into account, where costs are associated with implementing the intervention and control, and with taking measurements on subject and groups. The optimal design is found such that the effect of treatment is estimated with highest efficiency, and the total costs do not exceed the budget that is available. The design that is optimal for the outcome at the subject level is not necessarily optimal for the outcome at the group level. Multiple-objective optimal designs consider both outcomes simultaneously. Their aim is to find a design that has high efficiencies for both outcome measures. An Internet application for finding the multiple-objective optimal design is demonstrated on the basis of an example from smoking prevention in primary education, and another example on consultation time in primary care. |
format | Online Article Text |
id | pubmed-7082894 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | SAGE Publications |
record_format | MEDLINE/PubMed |
spelling | pubmed-70828942020-04-01 Optimal designs for group randomized trials and group administered treatments with outcomes at the subject and group level Moerbeek, Mirjam Stat Methods Med Res Regular Articles With group randomized trials complete groups of subject are randomized to treatment conditions. Such grouping also occurs in individually randomized trials where treatment is administered in groups. Outcomes may be measured at the level of the subject, but also at the level of the group. The optimal design determines the number of groups and the number of subjects per group in the intervention and control conditions. It is found by taking a budgetary constraint into account, where costs are associated with implementing the intervention and control, and with taking measurements on subject and groups. The optimal design is found such that the effect of treatment is estimated with highest efficiency, and the total costs do not exceed the budget that is available. The design that is optimal for the outcome at the subject level is not necessarily optimal for the outcome at the group level. Multiple-objective optimal designs consider both outcomes simultaneously. Their aim is to find a design that has high efficiencies for both outcome measures. An Internet application for finding the multiple-objective optimal design is demonstrated on the basis of an example from smoking prevention in primary education, and another example on consultation time in primary care. SAGE Publications 2019-05-01 2020-03 /pmc/articles/PMC7082894/ /pubmed/31041883 http://dx.doi.org/10.1177/0962280219846149 Text en © The Author(s) 2019 http://creativecommons.org/licenses/by-nc/4.0/ This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (http://www.creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage). |
spellingShingle | Regular Articles Moerbeek, Mirjam Optimal designs for group randomized trials and group administered treatments with outcomes at the subject and group level |
title | Optimal designs for group randomized trials and group administered treatments with outcomes at the subject and group level |
title_full | Optimal designs for group randomized trials and group administered treatments with outcomes at the subject and group level |
title_fullStr | Optimal designs for group randomized trials and group administered treatments with outcomes at the subject and group level |
title_full_unstemmed | Optimal designs for group randomized trials and group administered treatments with outcomes at the subject and group level |
title_short | Optimal designs for group randomized trials and group administered treatments with outcomes at the subject and group level |
title_sort | optimal designs for group randomized trials and group administered treatments with outcomes at the subject and group level |
topic | Regular Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7082894/ https://www.ncbi.nlm.nih.gov/pubmed/31041883 http://dx.doi.org/10.1177/0962280219846149 |
work_keys_str_mv | AT moerbeekmirjam optimaldesignsforgrouprandomizedtrialsandgroupadministeredtreatmentswithoutcomesatthesubjectandgrouplevel |